| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1011353757 |
| P356 | DOI | 10.1007/S10753-015-0151-Z |
| P698 | PubMed publication ID | 25761429 |
| P2093 | author name string | Jun Tian | |
| Xiangdong Yang | |||
| Tingting Xie | |||
| Huaibin Sun | |||
| Wanhua Xian | |||
| P2860 | cites work | Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations | Q46071688 |
| Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation | Q56942879 | ||
| PPARγ Activation Primes Human Monocytes into Alternative M2 Macrophages with Anti-inflammatory Properties | Q57244208 | ||
| Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease | Q59391845 | ||
| The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease | Q61863531 | ||
| Preventive effect of sulphated colominic acid on P-selectin-dependent infiltration of macrophages in experimentally induced crescentic glomerulonephritis | Q74417583 | ||
| CSF-1 signaling mediates recovery from acute kidney injury | Q28279068 | ||
| SIRPα interacts with nephrin at the podocyte slit diaphragm | Q28565762 | ||
| Alternative activation of macrophages: an immunologic functional perspective | Q29614353 | ||
| MicroRNA-29a promotion of nephrin acetylation ameliorates hyperglycemia-induced podocyte dysfunction | Q33974555 | ||
| Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study | Q34150807 | ||
| Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility | Q34403569 | ||
| Distinct macrophage phenotypes contribute to kidney injury and repair | Q34534902 | ||
| IL-25 induces M2 macrophages and reduces renal injury in proteinuric kidney disease | Q35108863 | ||
| Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease | Q35664554 | ||
| Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease | Q35698969 | ||
| Macrophages and the kidney | Q35741778 | ||
| Fibrotic disease and the T(H)1/T(H)2 paradigm | Q35852270 | ||
| Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis | Q36319395 | ||
| eNOS deficiency predisposes podocytes to injury in diabetes. | Q36352132 | ||
| Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease | Q36736700 | ||
| Macrophage diversity in renal injury and repair. | Q36955562 | ||
| Reversibility of structural and functional damage in a model of advanced diabetic nephropathy | Q36977327 | ||
| The pathogenesis of diabetic nephropathy | Q37209550 | ||
| Evaluation of the association of plasma pentraxin 3 levels with type 2 diabetes and diabetic nephropathy in a Malay population | Q37370584 | ||
| Recent insights in inflammation-associated wasting in patients with chronic kidney disease | Q37882287 | ||
| Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications | Q37944361 | ||
| The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression | Q38055945 | ||
| Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy | Q38094415 | ||
| Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity | Q39477901 | ||
| Protective effect of the long pentraxin PTX3 against histone-mediated endothelial cell cytotoxicity in sepsis | Q41737016 | ||
| mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice | Q41912848 | ||
| Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality | Q44571381 | ||
| P433 | issue | 5 | |
| P921 | main subject | macrophage | Q184204 |
| diabetic nephropathy | Q1129105 | ||
| P304 | page(s) | 1739-1747 | |
| P577 | publication date | 2015-03-13 | |
| P1433 | published in | Inflammation | Q2560341 |
| P1476 | title | Pentraxin-3 Attenuates Renal Damage in Diabetic Nephropathy by Promoting M2 Macrophage Differentiation | |
| P478 | volume | 38 |
| Q88634530 | Aerobic fitness alters the capacity of mononuclear cells to produce pentraxin 3 following maximal exercise |
| Q50962850 | Aqueous humor pentraxin-3 levels in patients with diabetes mellitus. |
| Q47148726 | Attenuation of partial unilateral ureteral obstruction - induced renal damage with hyperbaric oxygen therapy in a rat model |
| Q47216784 | Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update |
| Q38380295 | Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial |
| Q48036999 | Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy |
| Q92208806 | Overexpression of Sirt6 promotes M2 macrophage transformation, alleviating renal injury in diabetic nephropathy |
| Q99556551 | Pentraxin 3 promotes airway inflammation in experimental asthma |
| Q52761490 | Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study. |
| Q88035415 | Role of the Immune System in Diabetic Kidney Disease |
| Q90059408 | Roles of pattern recognition receptors in diabetic nephropathy |
| Q55447799 | Study on Association of Pentraxin 3 and Diabetic Nephropathy in a Rat Model. |
| Q37733630 | The Potential Role of Aerobic Exercise-Induced Pentraxin 3 on Obesity-Related Inflammation and Metabolic Dysregulation |
Search more.